<?xml version="1.0" encoding="UTF-8"?>
<p>Amodiaquine is a novel compound that is routinely prescribed as an antimalarial drug is reported to show antiviral effects against ebolavirus (Gignoux et al., 
 <xref rid="B19" ref-type="bibr">2016</xref>; Sakurai et al., 
 <xref rid="B53" ref-type="bibr">2018</xref>), dengue virus (Boonyasuppayakorn et al., 
 <xref rid="B5" ref-type="bibr">2014</xref>), and zika virus (Balasubramanian et al., 
 <xref rid="B3" ref-type="bibr">2017</xref>). The mechanism of inhibitory activity of amodiaquine against malaria and those viruses remains unclear.
</p>
